inVentiv, Medikly In Investigator Recruitment Pact

inVentiv Health, Inc. has entered a strategic partnership with Medikly, Inc., a provider of physician engagement solutions. The agreement also gives inVentiv exclusive access to Medikly’s platform and data-collection tools to use in clinical trial recruitment.
 
Medikly’s digital technology aims to help pharmaceutical companies identify, engage, and retain clinical trial investigators by applying a real-time view of doctors based on their preferences and behaviors online. Medikly allows trial sponsors to discover physicians likely to be interested in becoming trial investigators based on their work and characteristics that predispose them to research or to recommend patients for a trial. The technology also enables trial sponsors to create communities for investigators, develop medical education programs, then measure and apply engagement metrics to understand how healthcare providers will respond to messages.
 
“By now, we all know that digital technologies can streamline clinical trials and save costs, but the challenge is knowing which technologies to use and how to best deploy them to save the most money and time,” said Raymond Hill, president of Clinical for inVentiv Health. “This takes a special kind of expertise, grounded in broad global experience and deep insights into every aspect of drug development.  inVentiv Health has that expertise and it is what drives our investment in technologies like Medikly to accelerate clinical trial success.”
 
“With the Medikly platform, inVentiv will be able to help pharmaceutical clients capture and translate multichannel data into insights and interactive experiences that reach and engage physicians,” said Venkat Gullapalli, MD, chief executive officer and founder of Medikly. “inVentiv Health has had the foresight to leverage the right digital tools to position itself – and its customers – ahead of the curve.”